Version: 19.0.1 | Published: 26 Sep 2025 | Updated: 71 days ago
Genomics England - Transcriptomics
Dataset
Documentation
Associated Media:
Description:
The Genomics England 100kGP Transcriptomics Pilot and Extension comprises RNA-sequencing of a subset of rare disease probands from the 100,000 Genomes Project who did not receive a genetic diagnosis through the Genomics England Interpretation Pipeline (7840 samples from 7829 probands: 5546 samples in the initial Pilot project, 2294 samples in the Extension). We prioritised probands who were found to carry variants of unknown significance.
Priorities were based on:
- Variants highlighted through Splice AI
- Autosomal recessive disorders with only a single pathogenic variant identified
- GMC-selected VUS AND contribution to phenotype partial / unknown AND variant type likely to affect RNA processing
- Based on outcome questionnaire and a call to clinicians
- VUS with a high Exomiser score AND variant likely to results in detectable abnormal RNA processing
- Disorder category ranking by Genomics England on the basis of likely monogenic cause (ranks 1-5) for participants from 1.1 AND no diagnosis in outcome questionnaire
- Call to GMCs / clinicians to propose cases based on strong phenotype for a monogenic disorder with no lead from WGS
- Review whether RNA sample is available or requirement for fresh RNA sample
Is Part Of:
100k Genome Project
Coverage
Spatial:
UK
Typical Age Range:
0-150
Follow Up:
OTHER
Physical Sample Availability:
RNA
Pathway:
Linked datasets cover secondary care.
Provenance
Origin
Purposes:
- CARE
- DISEASE REGISTRY
- STUDY
Sources:
MACHINE GENERATED
Collection Situations:
CLINIC
Temporal
Accrual Periodicity:
QUARTERLY
Distribution Release Date:
11 September 2025
Start Date:
21 December 2023
Time Lag:
OTHER
Accessibility
Access
Access Rights:
Access Service:
More information about the Genomics England Research Environment can be found
here: https://www.genomicsengland.co.uk/research and
https://re-docs.genomicsengland.co.uk/welcome/. Genomics England 100k
participants have consented to longitudinal lifetime followup and recontact
safely through our clinical network.
Access Request Cost:
Fees will be dependent on the type of access that is necessary. Raw data is not
eligible for export. Summary-level data may be exported provided that it is
approved through the Genomics England Airlock Process
Delivery Lead Time:
2-6 MONTHS
Jurisdictions:
GB-GBN
Data Controller:
GENOMICS ENGLAND
Data Processor:
GENOMICS ENGLAND
Usage
Data Use Limitations:
GENERAL RESEARCH USE
Data Use Requirements:
- ETHICS APPROVAL REQUIRED
- PROJECT SPECIFIC RESTRICTIONS
- PUBLICATION MORATORIUM
Resource Creators:
- The 100
- 000 Genomes Project Protocol v3
- Genomics England. doi:10.6084/m9.figshare.4530893.v3. 2017. Publications that use the Genomics England Database should include an author as Genomics England Research Consortium. Please see the publication policy.
Is Referenced By:
Format and Standards
Vocabulary Encoding Schemes:
OTHER
Languages:
en
Formats:
- DRAGEN output
- RNA-Seq QC output
Enrichment and Linkage
Qualified Relations:
- HES Accident and Emergency
- HES Outpatient Care
- Diagnostic Imaging Dataset (DID)
- Patient Reported Outcome Measures (PROMs)
- Cancer Registration (AV) tables
- HES Admitted Patient Care
- Cancer waiting times (CWT)
- Lung Cancer Data Audit (LUCADA)
- PHE Diagnostic Imaging Dataset (NCRAS_DID)
- Systemic Anti-Cancer Therapy Data Set (SACT)
- Office for National Statistics - Death details data (ONS)
- National Radiotherapy Dataset (RTDS)
- Mental Health Minimum Data Set (MHMDS)
Tools:
Derivations:
Not Known
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
A subset of rare disease probands from the 100,000 Genomes Project who did not receive a genetic diagnosis through the Genomics England Interpretation Pipeline
7840 samples from 7829 probands: 5546 samples in the initial Pilot project, 2294 samples in the Extension
RNA-Seq
25 September 2025
Origin
Name:
Genomics England